Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells-Reference-Cited by-同舟云学术

Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells

Published:2017-12-31 Issue:12 Volume:50 Page:615-620
ISSN:1976-670X
Container-title:BMB Reports
language:en
Short-container-title:BMB Rep.

Author:

You Daeun¹,Jung Seung Pil²,Jeong Yisun¹,Bae Soo Youn²,Lee Jeong Eon¹³⁴,Kim Sangmin⁴

Affiliation:

1. Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Korea

2. Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Hospital, Korea University College of Medicine, Seoul 02852, Korea

3. Department of Surgery, Samsung Medical Center, Seoul 06351, Korea

4. Department of Breast Cancer Center, Samsung Medical Center, Seoul 06351, Korea

Funder

National Research Foundation of Korea(NRF)

Korea University(KU)

Ministry of Science, ICT and Future Planning(MSIP)

Publisher

Korean Society for Biochemistry and Molecular Biology - BMB Reports

Subject

Molecular Biology,Biochemistry,General Medicine

Reference32 articles.

1. Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study

2. Lim, E, Metzger-Filho, O, and Winer, EP (2012). The natural history of hormone receptor-positive breast cancer. Oncology (Williston Park). 26, Array-694.

3. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

4. Relationship Between Estrogen Levels, Use of Hormone Replacement Therapy, and Breast Cancer

5. Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine Strategies for Targeting Tumor Stroma;Cancers;2023-08-17

2. In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival;Cancers;2023-08-11

3. Shielding and nurturing: Fibronectin as a modulator of cancer drug resistance;Journal of Cellular Physiology;2023-06-03

4. Mechanistic insights into the development of severe fetal growth restriction;Clinical Science;2023-04

5. Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen;Frontiers in Oncology;2022-12-19